Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas
Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • CS1003 monoclonal antibody
  • Beijing, China
    Beijing Cancer Hospital
2022-01-12
Jan 12, 2022
N
Vaccine Responses in Patients With B Cell Malignancies
Not yet recruiting
  • Lymphoma
  • PNEUMOVAX 23
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-13
Jan 13, 2022
N
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost...
Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
  • +1 more
2022-01-13
Jan 13, 2022
H
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
Recruiting
  • Lymphoma
  • Rouen, France
    Centre Henri Becquerel; Hematologie
2022-01-12
Jan 12, 2022
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1384 more
2022-01-13
Jan 13, 2022
I
National Longitudinal Cohort of Hematological Diseases
Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    2022-01-11
    Jan 11, 2022
    J
    A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects
    Active, not recruiting
    • Lymphoma
    • New Process SHR2554 tablet、Former Process SHR2554 tablet
    • Former Process SHR2554 tablet、New Process SHR2554 tablet
    • Nanjing, Jiangsu, China
      the Affiliated Hospital of Nanjing University Medical School
    2021-12-31
    Dec 31, 2021
    A
    Early Integration of Palliative and Supportive Care in Hematopoietic Stem Cell Transplantation
    Not yet recruiting
    • Leukemia
    • +4 more
    • Early palliative and supportive care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    2021-12-29
    Dec 29, 2021
    N
    Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
    Recruiting
    • Leukemia
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-01-11
      Jan 11, 2022
      N
      Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
      Active, not recruiting
      • Melanoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-01-11
        Jan 11, 2022
        I
        Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment - 2008
        Completed
        Has Results
        • Lymphoma
        • +5 more
          • Agen, France
          • +17 more
          2021-11-09
          Nov 9, 2021
          D
          Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
          Recruiting
          • Solid Tumor, Childhood
          • +2 more
          • Boston, Massachusetts
          • +5 more
          2021-12-19
          Dec 19, 2021
          C
          A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas
          Recruiting
          • Lymphoma
          • Phoenix, Arizona
          • +31 more
          2022-01-08
          Jan 8, 2022
          J
          A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
          Active, not recruiting
          • Lymphoma, Non-Hodgkin
          • +9 more
          • lisocabtagene maraleucel
          • Los Angeles, California
          • +22 more
          2022-01-07
          Jan 7, 2022
          P
          FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma - 2021
          Completed
          • Lymphoma
          • FDG PET/CT guided metabolic core needle biopsy
          • (no location specified)
          2021-12-29
          Dec 29, 2021
          T
          Ixazomib Rollover Study
          Active, not recruiting
          • Multiple Myeloma
          • +2 more
          • Atlanta, Georgia
          • +23 more
          2021-12-20
          Dec 20, 2021
          C
          Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
          Recruiting
          • Lymphoma
          • Calgary, Alberta, Canada
          • +14 more
          2022-01-10
          Jan 10, 2022
          C
          CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
          Recruiting
          • Lymphoma, Non-Hodgkin
          • +6 more
          • CB-010
          • +2 more
          • Scottsdale, Arizona
          • +5 more
          2022-01-10
          Jan 10, 2022
          N
          A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas - 2017
          Completed
          • Neoplasms
          • Lymphoma
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-01-07
          Jan 7, 2022
          S
          S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma - 2015
          Completed
          Has Results
          • Lymphoma
          • rituximab
          • +7 more
          • Anchorage, Alaska
          • +47 more
          2021-12-22
          Dec 22, 2021
          A
          Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
          Recruiting
          • Lung Cancer
          • Lymphoma
          • DNA analysis
          • +6 more
          • La Jolla, California
          • +15 more
          2022-01-07
          Jan 7, 2022
          P
          Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
          Not yet recruiting
          • Lymphoma
          • +6 more
          • Digital Health Coaching
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          2022-01-05
          Jan 5, 2022
          F
          Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
          Not yet recruiting
          • Clinical Stage I Cutaneous Melanoma AJCC v8
          • +33 more
          • Informational Intervention
          • +4 more
          • Los Angeles, California
          • +4 more
          2022-01-04
          Jan 4, 2022
          M
          Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
          Recruiting
          • Breast Cancer
          • +2 more
          • Cardiac Imaging
          • Data Collection
          • Montréal, Quebec, Canada
          • +1 more
          2021-12-15
          Dec 15, 2021
          U
          Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma - 2015
          Terminated
          • Lymphoma
          • rituximab
          • +5 more
          • Manchester, England, United Kingdom
          • +4 more
          2021-12-16
          Dec 16, 2021